Primary Sclerosing Cholangitis clinical trials at UCSF
2 research studies open to eligible people
Primary sclerosing cholangitis is a condition where bile ducts suffer from long-term inflammation leading to scarring. At UCSF, current trials include gathering patient data globally and studying liver disease progression. These efforts help scientists create better models to study the illness.
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
open to eligible people ages 18-75
Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.
San Francisco, California and other locations
Liver Cirrhosis Network Cohort Study
open to eligible people ages 18 years and up
Liver Cirrhosis Network (LCN) Cohort Study is an observational study designed to identify risk factors and develop prediction models for risk of decompensation in adults with liver cirrhosis. LCN Cohort Study involves multiple institutions and an anticipated 1200 participants. Enrolled participants will have study visits every 6 months (180 days), with opportunities to complete specific visit components via telehealth or remotely. Visits will include collection of questionnaire data and the in-person visits will include questionnaires, physical exams, imaging, and sample collection.
San Francisco, California and other locations
Our lead scientists for Primary Sclerosing Cholangitis research studies include Michael Li, MD, MPH.
Last updated: